X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
ibandronate (663) 663
humans (576) 576
osteoporosis (451) 451
female (442) 442
bisphosphonates (410) 410
index medicus (379) 379
diphosphonates - therapeutic use (330) 330
zoledronic acid (262) 262
diphosphonates - administration & dosage (248) 248
bone density conservation agents - therapeutic use (243) 243
middle aged (235) 235
alendronate (223) 223
aged (221) 221
postmenopausal osteoporosis (205) 205
endocrinology & metabolism (201) 201
bone density conservation agents - administration & dosage (172) 172
male (168) 168
postmenopausal women (165) 165
bisphosphonate (163) 163
diphosphonates - adverse effects (160) 160
osteoporosis, postmenopausal - drug therapy (159) 159
women (153) 153
animals (146) 146
orthopedics (145) 145
oncology (143) 143
double-blind (142) 142
risedronate (135) 135
bone density - drug effects (131) 131
bone neoplasms - secondary (125) 125
osteoporosis - drug therapy (123) 123
pamidronate (123) 123
drug administration schedule (120) 120
bone density conservation agents - adverse effects (118) 118
medicine & public health (118) 118
bone-mineral density (117) 117
diphosphonates - pharmacology (116) 116
drug therapy (114) 114
treatment outcome (114) 114
randomized-trial (112) 112
monthly oral ibandronate (109) 109
fractures (106) 106
administration, oral (105) 105
pharmacology & pharmacy (104) 104
bone density (100) 100
care and treatment (100) 100
diphosphonates (100) 100
medicine, general & internal (93) 93
rheumatology (93) 93
breast cancer (92) 92
oral ibandronate (92) 92
bone neoplasms - drug therapy (91) 91
vertebral fractures (87) 87
risk factors (86) 86
aged, 80 and over (85) 85
bone mineral density (85) 85
adult (83) 83
analysis (83) 83
breast-cancer (82) 82
bone metastases (81) 81
therapy (81) 81
bones (80) 80
efficacy (79) 79
research (79) 79
nonvertebral fractures (77) 77
skeletal complications (74) 74
risk (72) 72
endocrinology (70) 70
ibandronic acid (70) 70
bisphosphonate ibandronate (66) 66
breast neoplasms - pathology (66) 66
phosphonates (66) 66
adherence (63) 63
clodronate (63) 63
prevention (63) 63
infusions, intravenous (62) 62
bone density conservation agents - pharmacology (61) 61
rats (61) 61
double-blind method (60) 60
cancer (59) 59
fracture risk (59) 59
fractures, bone - prevention & control (59) 59
health aspects (59) 59
density (58) 58
imidazoles - therapeutic use (58) 58
dose-response relationship, drug (57) 57
breast neoplasms - drug therapy (55) 55
pain (55) 55
multiple-myeloma (54) 54
persistence (54) 54
bone (53) 53
patient compliance (53) 53
randomized controlled trials as topic (53) 53
mineral density (52) 52
fracture (51) 51
hip fracture (50) 50
medicine, research & experimental (50) 50
denosumab (49) 49
dosage and administration (49) 49
quality of life (49) 49
safety (49) 49
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (875) 875
German (24) 24
French (10) 10
Spanish (9) 9
Russian (8) 8
Korean (4) 4
Portuguese (4) 4
Czech (3) 3
Polish (3) 3
Turkish (2) 2
Hungarian (1) 1
Italian (1) 1
Japanese (1) 1
Serbian (1) 1
Slovak (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Osteoporosis International, ISSN 0937-941X, 6/2012, Volume 23, Issue 6, pp. 1769 - 1778
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 08/2004, Volume 19, Issue 8, pp. 1241 - 1249
Journal Article
Osteoporosis International, ISSN 0937-941X, 3/2019, Volume 30, Issue 3, pp. 659 - 666
Using a nationwide database from the Korean National Health Insurance Service, this study showed that once-monthly oral ibandronate (150 mg) had better... 
Risedronate | Osteoporosis | Bisphosphonate | Medicine & Public Health | Ibandronate | Orthopedics | Rheumatology | Fracture | Endocrinology | POSTMENOPAUSAL | BISPHOSPHONATES | INTRAVENOUS IBANDRONATE | NONVERTEBRAL FRACTURES | SAFETY | ENDOCRINOLOGY & METABOLISM | RISK | Vertebrae | Databases | Fractures | Risedronic acid | Ibandronic acid | Population studies | Bisphosphonates | Hip | Geriatrics
Journal Article
Journal Article
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 09/2009, Volume 24, Issue 9, pp. 1544 - 1551
Journal Article
Journal Article